Personalization of Cover Letter and Response Rate

• ClinicalTrials.gov Identifier: NCT03046368
• Recruitment Status: Completed
• First Posted: February 8, 2017
• Last Update Posted: March 24, 2020
• Sponsor: University of Southern Denmark
• Information provided by (Responsible Party): Anne Illemann Christensen, University of Southern Denmark

Study Description

Brief Summary:

Several studies indicate that a survey that adapts personalized design features achieves higher participation rates. A feature can be a personalized cover letter which appears more relevant and interesting for the sample member. In the spirit of adaptive design, this study seeks to establish whether it can be advantageous for participation overall to use cover letters with targeted content and whether the effect on participation of different versions of the cover letter varies in sample subgroups in order to optimize design features in future surveys.

Condition or disease	Intervention/treatment	Phase
Response Rate	Behavioral: Targeted cover letter	Not Applicable

Detailed Description:

Background and aim: In the Danish Health and Morbidity Surveys the participation rate has declined from 61% in 2010 to 57% in 2013. A declining participation rate may affect the representativeness and the results of the survey. Several studies indicate that a survey that adapts personalized design features achieves higher participation rates. A feature can be a personalized cover letter which appears more relevant and interesting for the sample member. The research question, then, is whether cover letters with targeted content can perform better than a standard letter. The proposition is that such letters should increase the willingness of some sample members to participate, and that this will be reflected in higher response rates. However, little is known about which targeted content is the most effective.

Thus, in the spirit of adaptive design, this study seeks to establish whether it can be advantageous for participation overall to use cover letters with targeted content and whether the effect on participation of different versions of the cover letter varies in sample subgroups in order to optimize design features in future surveys. Further, given that the majority of sample members participate, these sample members who are swayed by the targeted letter must have relatively low response propensities (with the standard letter). Thus, we hypothesize that targeted letters should particularly improve response rates in low response propensity subgroups (i.e. young men, unmarried, and elderly women). A secondary research question is, therefore, whether any effect of targeted letters on response rate is greater among sample subgroups with low response propensities.

Design: A randomized trial will be incorporated the Danish Health and Morbidity Survey 2017 where a paragraph in the cover letter intended to heighten perceptions of relevance of the survey is varied among sample members. The Danish Health and Morbidity Survey 2017 will be based on a nationally representative random sample of 25,000 individuals (including institutionalized individuals) aged 16 years or older and resident in Denmark per 1 January 2017. The sample will be drawn from the adult population in Denmark using the Danish Civil Registration System and the survey will be conducted between February 3 and Maj 5, 2017. All sample members will be randomly allocated, with equal probabilities, to one of 11 treatment groups. One group will receive a standard letter that is designed to have general appeal and the other 10 groups will receive one of 10 versions of the targeted cover letter. In the previous Health and Morbidity Surveys, all sample members received the same standard letter. Much of the content of the standard letter and the targeted letter will be the same. The intention is to hold constant features designed to demonstrate the credibility of the survey, to allay fears about confidentiality, to appeal to self-interest, and to provide basic information about the task of participation. All sample members will be invited either to complete a web questionnaire or to fill out a paper questionnaire concerning health and morbidity.

Statistics: The analysis will be based on logistic regression modelling of the 25,000 persons invited to the Health and Morbidity Survey 2017. The independent variable is a dichotomous indicator of treatment group: targeted or standard letter. The dependent variable indicates whether the sample member has fully or partially completed the questionnaire. The mediator variable indicates membership of each of three operationally important low response propensity groups (i.e. young men, unmarried, and elderly women). The approach is to first test for a main effect of the independent variable in each of the treatment groups. A second step is to conduct the same analysis stratified by treatment group. A third step will then seek to identify whether any significant effects occurs between the mediator variable and dependent variable.

Study Design

• Study Type: Interventional (Clinical Trial)
• Actual Enrollment: 25000 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Single (Participant)
• Primary Purpose: Basic Science
• Official Title: Personalization of Cover Letter and Response Rate - a Randomized Controlled Trial in the Danish Health and Morbidity Survey
• Actual Study Start Date: February 3, 2017
• Actual Primary Completion Date: May 19, 2017
• Actual Study Completion Date: June 1, 2018

Arms and Interventions

Arm	Intervention/treatment
No Intervention: Standard cover letter; The group will receive a standard cover letter to the survey that is designed to have broad appeal: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark.
Experimental: Targeted cover letter 1; This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, alcohol and sleep problems.	Behavioral: Targeted cover letter; The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
Experimental: Targeted cover letter 2; This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, alcohol and contact to family and friends.	Behavioral: Targeted cover letter; The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
Experimental: Targeted cover letter 3; This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, alcohol and sex	Behavioral: Targeted cover letter; The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
Experimental: Targeted cover letter 4; This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, sleep problems and contact to family and friends.	Behavioral: Targeted cover letter; The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
Experimental: Targeted cover letter 5; This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, sleep problems and sex.	Behavioral: Targeted cover letter; The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
Experimental: Targeted cover letter 6; This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, sex and contact to family and friends.	Behavioral: Targeted cover letter; The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
Experimental: Targeted cover letter 7; This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as sex, sleep problems and contact to family and friends.	Behavioral: Targeted cover letter; The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
Experimental: Targeted cover letter 8; This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as sex, sleep problems and alcohol.	Behavioral: Targeted cover letter; The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
Experimental: Targeted cover letter 9; This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as sex, alcohol and contact to family and friends.	Behavioral: Targeted cover letter; The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
Experimental: Targeted cover letter 10; This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as alcohol, sleep problem and contact to family and friends.	Behavioral: Targeted cover letter; The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation

Outcome Measures

Primary Outcome Measures :

1. Overall response rate [ Time Frame: Up to 3 months (from February 3 2017 to maxium Maj 5 2017) ]
   Response rate overall and in the different intervention arms

Secondary Outcome Measures :

1. Response rate in different subgroups [ Time Frame: Up to 3 months (from February 3 2017 to maxium Maj 5 2017) ]
   Response rate in different subgroups with low response propensity

Eligibility Criteria

• Ages Eligible for Study: 16 Years and older (Child, Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

• individuals (including institutionalized individuals) aged 16 years or older and resident in Denmark per 1 January 2017.

Exclusion Criteria:

-

Contacts and Locations

Locations

Denmark

National Institute of Public health, University of Southern Denmark

Copenhagen, Denmark, 1353

Sponsors and Collaborators

University of Southern Denmark

Investigators

• Study Director: Janne S Tolstrup, MD PhD; National Institute of Public Health - University of Southern Denmark

More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Christensen AI, Lynn P, Tolstrup JS. Can targeted cover letters improve participation in health surveys? Results from a randomized controlled trial. BMC Med Res Methodol. 2019 Jul 17;19(1):151. doi: 10.1186/s12874-019-0799-4.

• Responsible Party: Anne Illemann Christensen, Postdoc, Ph.D., University of Southern Denmark
• ClinicalTrials.gov Identifier: NCT03046368
• Other Study ID Numbers: 60110-5060-FL
• First Posted: February 8, 2017
• Last Update Posted: March 24, 2020
• Last Verified: March 2020

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: No

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No